new weight loss drug glp-1 drugs are about to ship to more American homes GLP-1 weight loss drugs may

On October 23, Lilly and Mumbai-based Cipla announced a joint agreement to distribute and promote tirzepatide under the brand Yurpeak

Eli Lillys daily anti-obesity pill orforglipron appears to be as good at spurring weight loss and lowering blood sugar in diabetes patients as popular injectable GLP-1 drugs like Ozempic, according to new data from a Phase 3 trial

You don't have to prove you've had a heart attack to get help managing a disease that could cause one

GLP-1 Probiotic

doi: 10.1016/j.molmet.2018.09.009 64 BerndtSIGustafssonSMgiRGannaAWheelerEFeitosaMFet al

Various cases have reported allergic reactions, ranging from mild to severe, including instances of StevensJohnson syndrome [77]